LEAMINGTON, ON, Nov. 18, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company that inspires and empowers the entire community to live their best lives, today announces the launch of its medical cannabis division, Tilray Medical. take back controlAnd the A new platform developed to connect women with free medical cannabis resources and to help destigmatize medical cannabis use in women’s healthcare practices. The take back control A platform that connects people for free consultations with healthcare practitioners who focus on women’s health and provide expert advice on medical cannabis.
Take Back Control is designed to help women make informed decisions about medical cannabis and help them along the way to discovering how medical cannabis can play a role in their daily healthcare practices. Now available in Canada, Take Back Control streamlines the steps for meeting with a healthcare practitioner to help women with their needs and challenges, and provides professional guidance to help begin their medical cannabis healthcare journey.
Tilray Medical is the world’s leading manufacturer of medical cannabis and is committed to helping people regain control of their healthcare and treatment choices. Unlike some other alternatives, medical cannabis allows people to become active participants in their own healthcare journey.
For more information on Take Back Control visit www.takebackcontrolnow.ca
About Tilray Medical
Tilray Medical is dedicated to transforming patients’ lives and enhancing their dignity through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast and Symbios. Tilray has grown from being one of the first companies to become an approved licensed medical cannabis producer in Canada to building the first EU and GMP certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the largest suppliers of brands of medical cannabis to patients, physicians, hospitals, pharmacies, researchers, and governments, in 20 countries and across five continents.
About Tilray Brands
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global manufacturer of cannabis products and consumer packaged goods with operations in Canada, the United States, Europe, Australia and Latin America that is transforming people’s lives for the better–one person at a time. Tilray Brands fulfills this mission by inspiring and empowering society around the world to live their best lives and providing access to products that fulfill the needs of their mind, body, and spirit while evoking luxury. Patients and consumers trust Tilray Brands to deliver an implanted experience, health and well-being through premium quality brands and innovative products. A leader in hemp research, cultivation and distribution, Tilray’s unparalleled production platform supports more than 20 brands in more than 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages.
For more information on how to unlock a world of luxury, visit www.Tilray.com Follow @Tilray on Instagram and Twitter.
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, which are intended to be subject to the “safe harbor” established by those departments and other applicable laws. Forward-looking statements can be identified by words such as “expect,” “future,” “should,” “could,” “enable,” “potential,” “believe,” “expect,” “estimate,” “plan,” “expect,” “intends,” “may,” “project,” “will,” “will” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, objectives, expectations or assumptions have been used in drawing the conclusions contained in the forward-looking statements during this communication. Forward-looking statements include statements regarding our current intentions, beliefs, expectations, projections, analyses, or expectations regarding, among other things: expectations regarding the performance and size of the company, including Tilray Medical; and the company’s ability to expand its offerings to patients around the world, including via Tilray Medical. Many factors could cause actual results, performance or achievement to differ materially from any forward-looking statements, and other risks and uncertainties not currently known to the Company or that the Company considers immaterial could also cause actual results or events to differ materially from those expressed in the statements forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see Tilray’s most recent Annual Information Form and Annual Report on Form 10-K (and Other Periodic Reports to the SEC) that were filed with the SEC and are available at Edgar . The forward-looking statements included in this communication are being made as of the date of this communication and the Company undertakes no obligation to publicly update these forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.